The better performance status, the better outcome: Laryngeal carcinoma treated with definitive radiotherapy

Journal of Otolaryngology - Head and Neck Surgery

Volumn 37, Issue 6, 2008, Pages 799-806

  Yurut Caloglu, Vuslat ^a   Caloglu, Murat ^a   Turan, Fatma Nesrin ^a   Ibis, Kamuran ^a   Karagol, Hakan ^a   Kocak, Zafer ^a   Uzal, Cem ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Carcinoma; Larynx; Performance status; Prognostic factors; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 64349123678     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2008.OA0173     Document Type: Article

References (28)

1. Jorgensen K, Godballe C, Hansen O, et al. Cancer of the larynx-treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 2002;41:69-76.
2. Mowry SE, LoTempio MM, Sadeghi A, et al. Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation. Otolaryngol Head Neck Surg 2006;135:565-70.
3. Finizia C, Geterud A, Holmberg E, et al. Advanced laryngeal cancer T3-T4 in Sweden: a retrospective study 1986-1990. Survival and locoregional control related to treatment. Acta Otolaryngol (Stockh) 1996;116:906-12.
4. Nguyen-Tan PF, Le QT, Quivey JM, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001;50:1172-80.
5. Parsons JT, Mendenhall WM, Stringer SP, et al. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998;40:549-52.
6. Karim AB, Kralendonk JH, Njo KH, et al. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 1987;13:1625-33.
7. Mendenhall WM, Parsons JT, Mancuso AA, et al. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996;18:24-35.
8. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
9. Dische S, Saunders M, Barrett A, et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
10. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933-40.
11. Featherstone CJ, Clarke S, Jackson MA, et al. Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation. Aust N Z J Surg 2004;74:554-8.
12. Newman LA, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:589-92.
13. Mangar S, Slevin N, Mais K, et al. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol 2006;78:152-8.
14. Cooper JS, Farnan NC, Asbell SO, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 1996;77: 1905-11.
15. Ovesen L, Allingstrup L, Hannibal J, et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993;11:2043-9.
16. Ravasco P, Monteiro-Grillo I, Vidal PM, et al. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 2004;12:246-52.
17. Ravasco P, Monteiro-Grillo I, Marques Vidal P, et al. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005;27:659-68.
18. Mendenhall WM. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 1998;8: 262-9.
19. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129:44-9.
20. MacKenzie RG, Franssen E, Balogh JM, et al. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 2000;47:65-71.
21. Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 2003;25:953-9.
22. Wang CC, McIntyre J. Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 1993;26:783-5.
23. Tarnawski R, Widel M, Skladowski K. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture. Int J Radiat Oncol Biol Phys 2003;55:1074-81.
24. Suwinski R, Sowa A, Rutkowski T, et al. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 2003;56:399-412.
25. Fu KK, Clery M, Ang KK, et al. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys 1995;32:589-97.
26. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
27. Monnerat C, Faivre S, Temam S, et al. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002;13:995-1006.
28. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.